Preparation of Photolabeled DTA. DTA (0.7-1.1 ,umol) was irradiated (3) in the presence of unlabeled or isotopically labeled NAD, generating the corresponding photoaffinitylabeled DTA analogs. For nonradioactive preparations of NAD, [carbonyl-14C]NAD was included in the reaction mixture at a final concentration of 5 mol % to facilitate identification and purification of the photoproducts. Five different preparations of photolabeled DTA were made and analyzed for the studies described.
catalyzes the ADP-ribosyltransferase and NAD-glycohydrolase reactions of the toxin and contains a single high-affinity (Kd = 8 ,uM) NAD binding site (2) . The remainder of the molecule (the B chain, 342 residues) is involved in binding DT to receptor-bearing cells and transporting the enzymically active A chain into the cytosol.
Irradiation of mixtures of DTA and NAD with UV light induces efficient (=1 mol/mol) transfer of iabel from [carbonyl-'4C]NAD to the A fragment, whereas label in the adenine or in the adenylate phosphate is transferred only poorly (3) . Virtually all (94%) of the transferred carbonyl label is found associated with position 148 of photoaffinitylabeled (4) DTA, which corresponds to a glutamic acid residue in the native molecule. We inferred from these and other results that Glu-148 lay within the nicotinamide subsite and might reside at or near the catalytic center of the toxin.
Here we report the structure of the photoproduct formed at position 148.
MATERIALS AND METHODS
Materials. DTA was purified by size-exclusion chromatography of nicked and reduced DT (2) and was quantified by measuring the absorption at 280 nm (AI%'m = 15). NAD (100% free acid) was obtained from Boehringer Mannheim.
[carbonyl-14C]NAD (56 mCi/mmol; 1 Ci = 37 GBq) and (5) with an isotopic purity of 99% was prepared from [1-15N] nicotinamide (6) by exchange into the thionicotinamide analog of NAD according to the procedure of Williams et al. (7) . The same procedure was used to prepare [Nic4-'3C]NAD from [4-13C] nicotinamide at an isotopic enrichment of 99% (unpublished results). The concentrations of all NAD preparations were determined using an Al`of 17.8 at 259 nm.
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Mixtures of DTA (100 ,uM) and NAD (200 ,uM) in 50 mM Tris Cl (pH 7.2) were prepared at 0°C and transferred to an ice-cold inverted microtiter plate lid. The shallow films (-2 mm thick) were irradiated at a distance of 5.0 cm with a 15-W germicidal lamp (G15-T8; General Electric). The intensity of UV light received by the samples was 2.8 mW/cm2, as assayed by radiometry at 254 nm (model UVX; UVP, San Gabriel, CA). After 60 min, photolyzed DTA was separated from unreacted NAD and reaction byproducts, by gel filtration on a 0.7 x 20 cm column of Sephadex G-50 fine equilibrated in 5.7% (vol/vol) 
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Proc. Natl. Acad. Sci. USA 82 (1985) tripeptide Val-Xaa-Tyr (residues 147-149), where Xaa represents the photolabeled amino acid at position 148 (3). This tripeptide was isolated from DTA irradiated in the presence of unlabeled or various isotopically labeled NAD preparations essentially as described (3) , except that the cyanogen bromide cleavage step was omitted.
Photolabeled DTA was resuspended in 0.2 M Nethylmorpholine/acetate buffer (pH 8.2) to a concentration of 5.0 mg/ml and digested with thermolysin (Sigma) (0.1 mg/ml) at 45°C for 10 hr. The reaction was terminated by the addition of glacial acetic acid, followed by lyophilization. The digest was dissolved in a minimal volume of 98% formic acid, diluted with 30% acetic acid (vol/vol), and chromatographed on a 0.4 x 110 cm column of Sephadex G-25 fine in 30% acetic acid. The (wt/vol) trichloroacetic acid. After several washes in 5% trichloroacetic acid to remove unreacted ligand, acid-precipitable radioactivity was determined. (9) , and this fluorescence can be enhanced by the addition of ketones (10) . Neither the photoproduct nor labeled peptides derived from it exhibited significant 430 nm fluorescence under these conditions (data not shown), even though two-orders-of-magnitude lower concentrations of Nmethylnicotinamide or nicotinamide mononucleotide were readily detected. We concluded that the protein-associated nicotinamide either was not substituted on the ring nitrogen or was attached in a manner that prevented fluorescence at 430 nm.
Mass Spectrometric Measurements. We isolated the thermolytic tripeptide, Val-Xaa-Tyr (residues 147-149) from fragment A irradiated in the presence of either native NAD (generating an isotopically unlabeled photoproduct at position 148) or NAD containing 13C at C-4 of the nicotinamide moiety. Mass spectra of these peptides were then determined by fast-atom bombardment.
A low-resolution fast-atom-bombardment spectrum of the 12C-photolabeled tripeptide is shown in Fig. 2 Table 2 . The most obvious differences in the two spectra are the shifts of the y-CH2 of the glutamic acid residue. Normally, the chemical shifts of these protons occur at about 2.3 ppm and 2.5 ppm for the deprotonated and protonated forms of this carboxylic acid, respectively. In the photoproduct spectrum, however, the corresponding resonances were observed at 2.927 and 2.85 ppm. Only three proton resonances arising from the nicotinamide moiety were detected in the photoproduct spectrum (Fig. 3) ; a narrow doublet at 8.820 ppm (nicotinamide-2, J = 2.2 Hz), a doublet of doublets at 8.152 ppm (nicotinamide-4, J = 2.2, 8.0 Hz), and a doublet at 7.446 ppm (nicotinamide-5, J = 8.0 Hz). No resonances attributable to any of the remaining portions of the dinucleotide were observed, thus confirming that formation of the photoproduct occurs by cleavage of the nicotinamide-ribosyl linkage and loss of the ADP-ribose moiety. From the homonuclear spin-spin splitting pattern of the three photoproduct protons, it was evident that either the nicotinamide-4 or the nicotinamide-6 proton had been lost (an 8.0 Hz coupling would correspond to either the nicotinamide-4-5 or the nicotinamide-5-6 vicinal coupling constant, and the small coupling of 2.2 Hz would correspond to either the nicotinamide-2-6 or the nicotinamide-2-4 long-range, 4-bond coupling).
The site of attachment was conclusively determined by using photolabeled tripeptides prepared from [Nic4-13C]NAD or [Nicl-15N]NAD. The spectrum of the '3C-labeled photoproduct (Fig. 3 Inset) shows that the resonance at 8.152 ppm is now split by a large 165 Hz 1J13C_1H heteronuclear coupling, thus assigning this resonance to the proton on nicotinamide C-4. The spectrum of the photoproduct derived from [Nicl-15N]NAD (Fig. 3 Inset) show a 9.6 Hz J1SNlH heteronuclear coupling to the proton on nicotinamide C-2 but not to any other resonances of the nicotinamide ring. If a proton were present at carbon 6, then a geminal 'H-15N coupling of 9-10 Hz would have been expected (5) . These results establish that the photoproduct contains a linkage to the C-6 position in an otherwise unmodified nicotinamide moiety and confirm our observation that the proton at position 4 is retained in the product (Fig.  1) .
The 'H-NMR spectra of the Glu-148 y-CH2 resonances for the unlabeled and 15N-labeled tripeptide photoproducts are compared in Fig. 5 . A 1-1.5 Hz 3J15N_1H heteronuclear coupling constant from 15N to the y-CH2 protons was observed. The y-CH2 of Glu-148 must therefore be covalently attached to C-6 of nicotinamide. The strong deshielding of these protons relative to the corresponding protons in an unmodified glutamate is fully consistent with a linkage to an aromatic ring.
DISCUSSION
Fig . 6 shows the structure of the photoproduct formed at position 148 when DTA is irradiated in the presence of NAD. Irradiation brings about decarboxylation of Glu-148, scission of the bond linking ADP-ribose to nicotinamide, and formation of a new carbon-carbon bond between the y-methylene carbon of Glu-148 and carbon-6 of the nicotinamide ring. The photoproduct may be termed an a-amino-y(6-nicotinamidyl)butyric acid residue. The other products have not been identified, but are formally equivalent to ADP-ribose and formic acid.
We assume that the photochemical reaction described here results from excitation of the nicotinamide ring of bound NAD, but the reaction mechanism remains to be explored. Photoexcitation of complexes of oxidized lactate oxidase and carboxylic acids is known to induce decarboxylation of the tightly bound acid and formation of covalent adducts at a specific site on the flavin, the nitrogen at ring position 5 (12) . Irradiation of peptides in the presence of anthraquinone antitumor agents also induces a decarboxylation reaction that appears specific for the carboxyl-terminal amino acid (13 (3) . More extensive studies are needed to determine the range of enzymes to which this photolabeling method may be applicable. Replacement of essential active-site residues is an ideal approach to preparing biologically inactive, but immunogenic, forms ofbacterial toxins for use in vaccination. In the case of DT, although the formalin-treated toxin (toxoid) has long served as an effective vaccine against diphtheria, substitution of an enzymically inactive form would minimize potential hazards in toxin production and eliminate the possibility of reversion of the formalin-treated molecule to a toxic state. More important, there are other ADP-ribosylating toxins, including exotoxin A, for which effective vaccines are being sought. Photolabeling with nicotinamide-labeled NAD to identify active-site residues, coupled with site-directed mutagenesis ofthese residues, may provide safe and effective toxoids of such toxins.
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